nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—hypertension—obesity	0.304	1	CtDrD
Propranolol—ADRB3—obesity	0.0958	0.427	CbGaD
Propranolol—Isoxsuprine—Phenylpropanolamine—obesity	0.0896	0.587	CrCrCtD
Propranolol—HTR1B—obesity	0.049	0.218	CbGaD
Propranolol—ADRB1—obesity	0.0433	0.193	CbGaD
Propranolol—Propafenone—Benzphetamine—obesity	0.0381	0.25	CrCrCtD
Propranolol—ADRB2—obesity	0.0364	0.162	CbGaD
Propranolol—ORM1—Bupropion—obesity	0.0279	0.135	CbGbCtD
Propranolol—ADRB2—Phenylpropanolamine—obesity	0.0259	0.125	CbGbCtD
Propranolol—ADRB1—Phenylpropanolamine—obesity	0.0255	0.123	CbGbCtD
Propranolol—Atomoxetine—Benzphetamine—obesity	0.0249	0.163	CrCrCtD
Propranolol—SLC22A2—Cimetidine—obesity	0.0169	0.0818	CbGbCtD
Propranolol—CYP3A7—Cimetidine—obesity	0.00924	0.0446	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00924	0.0446	CbGbCtD
Propranolol—CYP1A2—Phentermine—obesity	0.00827	0.0399	CbGbCtD
Propranolol—CYP1A2—Phenylpropanolamine—obesity	0.00788	0.038	CbGbCtD
Propranolol—CYP1A2—Bupropion—obesity	0.00703	0.0339	CbGbCtD
Propranolol—CYP3A5—Cimetidine—obesity	0.00693	0.0334	CbGbCtD
Propranolol—CYP2D6—Phentermine—obesity	0.00681	0.0329	CbGbCtD
Propranolol—CYP2D6—Bupropion—obesity	0.00579	0.0279	CbGbCtD
Propranolol—CYP3A4—Sibutramine—obesity	0.00571	0.0276	CbGbCtD
Propranolol—CYP2C19—Cimetidine—obesity	0.00559	0.027	CbGbCtD
Propranolol—CYP2D6—Methamphetamine—obesity	0.00544	0.0263	CbGbCtD
Propranolol—CYP1A2—Cimetidine—obesity	0.00516	0.0249	CbGbCtD
Propranolol—ABCB1—Cimetidine—obesity	0.00451	0.0218	CbGbCtD
Propranolol—CYP3A4—Benzphetamine—obesity	0.00433	0.0209	CbGbCtD
Propranolol—CYP2D6—Cimetidine—obesity	0.00425	0.0205	CbGbCtD
Propranolol—CYP3A4—Bupropion—obesity	0.00368	0.0178	CbGbCtD
Propranolol—CYP2C19—Topiramate—obesity	0.00366	0.0177	CbGbCtD
Propranolol—ADRB3—brown adipose tissue—obesity	0.00338	0.266	CbGeAlD
Propranolol—CYP3A4—Orlistat—obesity	0.003	0.0145	CbGbCtD
Propranolol—CYP3A4—Cimetidine—obesity	0.0027	0.013	CbGbCtD
Propranolol—ORM1—bile—obesity	0.00183	0.144	CbGeAlD
Propranolol—CYP3A4—Topiramate—obesity	0.00177	0.00854	CbGbCtD
Propranolol—ORM1—gall bladder—obesity	0.000507	0.0399	CbGeAlD
Propranolol—ADRB3—adipose tissue—obesity	0.000457	0.036	CbGeAlD
Propranolol—HTR1A—hindbrain—obesity	0.000388	0.0306	CbGeAlD
Propranolol—CYP3A7—endocrine gland—obesity	0.00026	0.0205	CbGeAlD
Propranolol—SLC22A2—digestive system—obesity	0.000259	0.0204	CbGeAlD
Propranolol—CYP3A7—liver—obesity	0.000235	0.0185	CbGeAlD
Propranolol—HTR1B—cardiovascular system—obesity	0.000225	0.0177	CbGeAlD
Propranolol—ADRB1—cardiovascular system—obesity	0.000212	0.0167	CbGeAlD
Propranolol—CYP2D6—hindbrain—obesity	0.000211	0.0166	CbGeAlD
Propranolol—CYP3A7-CYP3A51P—liver—obesity	0.0002	0.0157	CbGeAlD
Propranolol—Insomnia—Phenylpropanolamine—obesity	0.000189	0.0038	CcSEcCtD
Propranolol—Duloxetine—NPY1R—obesity	0.000187	0.0725	CrCbGaD
Propranolol—ADRB1—adipose tissue—obesity	0.000187	0.0147	CbGeAlD
Propranolol—Purpura—Sibutramine—obesity	0.000186	0.00375	CcSEcCtD
Propranolol—Agitation—Cimetidine—obesity	0.000186	0.00375	CcSEcCtD
Propranolol—Dyspnoea—Phenylpropanolamine—obesity	0.000186	0.00375	CcSEcCtD
Propranolol—Anaphylactoid reaction—Sibutramine—obesity	0.000186	0.00374	CcSEcCtD
Propranolol—Somnolence—Phenylpropanolamine—obesity	0.000186	0.00374	CcSEcCtD
Propranolol—CYP3A5—islet of Langerhans—obesity	0.000185	0.0145	CbGeAlD
Propranolol—Convulsion—Diethylpropion—obesity	0.000184	0.00371	CcSEcCtD
Propranolol—Hypoglycaemia—Sibutramine—obesity	0.000184	0.00371	CcSEcCtD
Propranolol—Dizziness—Methamphetamine—obesity	0.000184	0.0037	CcSEcCtD
Propranolol—Diarrhoea—Benzphetamine—obesity	0.000183	0.00369	CcSEcCtD
Propranolol—HTR1A—cardiovascular system—obesity	0.000182	0.0143	CbGeAlD
Propranolol—Sleep disorder—Bupropion—obesity	0.000181	0.00364	CcSEcCtD
Propranolol—CYP1A2—respiratory system—obesity	0.000181	0.0142	CbGeAlD
Propranolol—Insomnia—Phentermine—obesity	0.000181	0.00364	CcSEcCtD
Propranolol—Rash erythematous—Topiramate—obesity	0.00018	0.00361	CcSEcCtD
Propranolol—Constipation—Phenylpropanolamine—obesity	0.000178	0.00359	CcSEcCtD
Propranolol—CYP1A1—respiratory system—obesity	0.000178	0.014	CbGeAlD
Propranolol—Dizziness—Benzphetamine—obesity	0.000177	0.00357	CcSEcCtD
Propranolol—Affect lability—Sibutramine—obesity	0.000177	0.00356	CcSEcCtD
Propranolol—Dyspepsia—Phentermine—obesity	0.000176	0.00354	CcSEcCtD
Propranolol—Disorientation—Bupropion—obesity	0.000175	0.00353	CcSEcCtD
Propranolol—CYP3A5—respiratory system—obesity	0.000174	0.0137	CbGeAlD
Propranolol—Gastrointestinal disorder—Phentermine—obesity	0.000172	0.00347	CcSEcCtD
Propranolol—Fatigue—Phentermine—obesity	0.000172	0.00347	CcSEcCtD
Propranolol—Cardiac arrest—Sibutramine—obesity	0.000171	0.00344	CcSEcCtD
Propranolol—Constipation—Phentermine—obesity	0.000171	0.00344	CcSEcCtD
Propranolol—Mood swings—Sibutramine—obesity	0.00017	0.00343	CcSEcCtD
Propranolol—Diarrhoea—Phendimetrazine—obesity	0.000167	0.00337	CcSEcCtD
Propranolol—Amnesia—Bupropion—obesity	0.000167	0.00336	CcSEcCtD
Propranolol—Dermatitis exfoliative—Bupropion—obesity	0.000166	0.00334	CcSEcCtD
Propranolol—Visual disturbance—Bupropion—obesity	0.000165	0.00333	CcSEcCtD
Propranolol—Anaphylactic shock—Cimetidine—obesity	0.000165	0.00333	CcSEcCtD
Propranolol—ORM1—endocrine gland—obesity	0.000165	0.013	CbGeAlD
Propranolol—Dizziness—Phendimetrazine—obesity	0.000162	0.00325	CcSEcCtD
Propranolol—Hypoglycaemia—Bupropion—obesity	0.000161	0.00323	CcSEcCtD
Propranolol—Lethargy—Bupropion—obesity	0.00016	0.00322	CcSEcCtD
Propranolol—Nausea—Benzphetamine—obesity	0.000159	0.00321	CcSEcCtD
Propranolol—Urticaria—Phentermine—obesity	0.000159	0.00319	CcSEcCtD
Propranolol—Abdominal pain—Phentermine—obesity	0.000158	0.00318	CcSEcCtD
Propranolol—Bronchospasm—Orlistat—obesity	0.000158	0.00318	CcSEcCtD
Propranolol—Insomnia—Diethylpropion—obesity	0.000157	0.00316	CcSEcCtD
Propranolol—Dyspnoea—Diethylpropion—obesity	0.000155	0.00312	CcSEcCtD
Propranolol—Somnolence—Diethylpropion—obesity	0.000154	0.00311	CcSEcCtD
Propranolol—HTR1B—endocrine gland—obesity	0.000154	0.0122	CbGeAlD
Propranolol—Affect lability—Bupropion—obesity	0.000154	0.0031	CcSEcCtD
Propranolol—Hypersensitivity—Phenylpropanolamine—obesity	0.000154	0.0031	CcSEcCtD
Propranolol—Dyspepsia—Diethylpropion—obesity	0.000153	0.00308	CcSEcCtD
Propranolol—Gastrointestinal disorder—Diethylpropion—obesity	0.00015	0.00302	CcSEcCtD
Propranolol—Irritability—Bupropion—obesity	0.00015	0.00301	CcSEcCtD
Propranolol—Bronchitis—Sibutramine—obesity	0.000149	0.00301	CcSEcCtD
Propranolol—Constipation—Diethylpropion—obesity	0.000149	0.00299	CcSEcCtD
Propranolol—ORM1—liver—obesity	0.000149	0.0117	CbGeAlD
Propranolol—Mood swings—Bupropion—obesity	0.000148	0.00299	CcSEcCtD
Propranolol—Somnolence—Cimetidine—obesity	0.000147	0.00296	CcSEcCtD
Propranolol—ADRB1—endocrine gland—obesity	0.000145	0.0114	CbGeAlD
Propranolol—Nausea—Phendimetrazine—obesity	0.000145	0.00292	CcSEcCtD
Propranolol—HTR1A—adrenal gland—obesity	0.000144	0.0113	CbGeAlD
Propranolol—Asthenia—Phentermine—obesity	0.000143	0.00288	CcSEcCtD
Propranolol—Infestation—Orlistat—obesity	0.000143	0.00288	CcSEcCtD
Propranolol—Infestation NOS—Orlistat—obesity	0.000143	0.00288	CcSEcCtD
Propranolol—Erectile dysfunction—Sibutramine—obesity	0.000143	0.00288	CcSEcCtD
Propranolol—Depression—Orlistat—obesity	0.000143	0.00287	CcSEcCtD
Propranolol—Fatigue—Cimetidine—obesity	0.000143	0.00287	CcSEcCtD
Propranolol—Atrioventricular block—Topiramate—obesity	0.000142	0.00285	CcSEcCtD
Propranolol—Constipation—Cimetidine—obesity	0.000141	0.00285	CcSEcCtD
Propranolol—CYP2C19—digestive system—obesity	0.000141	0.0111	CbGeAlD
Propranolol—Depression—Sibutramine—obesity	0.000138	0.00278	CcSEcCtD
Propranolol—Urticaria—Diethylpropion—obesity	0.000138	0.00278	CcSEcCtD
Propranolol—Dizziness—Phenylpropanolamine—obesity	0.000138	0.00278	CcSEcCtD
Propranolol—Diarrhoea—Phentermine—obesity	0.000137	0.00275	CcSEcCtD
Propranolol—Bronchospasm—Bupropion—obesity	0.000133	0.00268	CcSEcCtD
Propranolol—Vomiting—Phenylpropanolamine—obesity	0.000133	0.00267	CcSEcCtD
Propranolol—Dizziness—Phentermine—obesity	0.000132	0.00266	CcSEcCtD
Propranolol—Rash—Phenylpropanolamine—obesity	0.000132	0.00265	CcSEcCtD
Propranolol—Dermatitis—Phenylpropanolamine—obesity	0.000131	0.00265	CcSEcCtD
Propranolol—Body temperature increased—Cimetidine—obesity	0.000131	0.00263	CcSEcCtD
Propranolol—Bronchitis—Bupropion—obesity	0.00013	0.00262	CcSEcCtD
Propranolol—Pharyngitis—Orlistat—obesity	0.000128	0.00257	CcSEcCtD
Propranolol—Dry eye—Topiramate—obesity	0.000127	0.00256	CcSEcCtD
Propranolol—Vomiting—Phentermine—obesity	0.000127	0.00256	CcSEcCtD
Propranolol—Bradycardia—Sibutramine—obesity	0.000127	0.00255	CcSEcCtD
Propranolol—Rash—Phentermine—obesity	0.000126	0.00254	CcSEcCtD
Propranolol—Dermatitis—Phentermine—obesity	0.000126	0.00253	CcSEcCtD
Propranolol—Erectile dysfunction—Bupropion—obesity	0.000125	0.00251	CcSEcCtD
Propranolol—HTR1A—endocrine gland—obesity	0.000125	0.00981	CbGeAlD
Propranolol—Nausea—Phenylpropanolamine—obesity	0.000124	0.0025	CcSEcCtD
Propranolol—Pharyngitis—Sibutramine—obesity	0.000123	0.00248	CcSEcCtD
Propranolol—Hypersensitivity—Cimetidine—obesity	0.000122	0.00245	CcSEcCtD
Propranolol—Infestation NOS—Bupropion—obesity	0.000121	0.00243	CcSEcCtD
Propranolol—Infestation—Bupropion—obesity	0.000121	0.00243	CcSEcCtD
Propranolol—CYP1A1—adipose tissue—obesity	0.00012	0.00948	CbGeAlD
Propranolol—Visual impairment—Sibutramine—obesity	0.00012	0.00241	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Bupropion—obesity	0.00012	0.00241	CcSEcCtD
Propranolol—Diarrhoea—Diethylpropion—obesity	0.000119	0.00239	CcSEcCtD
Propranolol—Nausea—Phentermine—obesity	0.000119	0.00239	CcSEcCtD
Propranolol—Asthenia—Cimetidine—obesity	0.000119	0.00239	CcSEcCtD
Propranolol—CYP3A5—adipose tissue—obesity	0.000118	0.00927	CbGeAlD
Propranolol—CYP2C19—endocrine gland—obesity	0.000116	0.00916	CbGeAlD
Propranolol—Sleep disorder—Topiramate—obesity	0.000115	0.00232	CcSEcCtD
Propranolol—Carvedilol—NPPB—obesity	0.000115	0.0446	CrCbGaD
Propranolol—CYP1A2—digestive system—obesity	0.000115	0.00905	CbGeAlD
Propranolol—Dizziness—Diethylpropion—obesity	0.000115	0.00231	CcSEcCtD
Propranolol—Alopecia—Orlistat—obesity	0.000114	0.00229	CcSEcCtD
Propranolol—CYP1A1—digestive system—obesity	0.000113	0.00893	CbGeAlD
Propranolol—Diarrhoea—Cimetidine—obesity	0.000113	0.00228	CcSEcCtD
Propranolol—Mental disorder—Orlistat—obesity	0.000113	0.00227	CcSEcCtD
Propranolol—Vascular purpura—Topiramate—obesity	0.000112	0.00225	CcSEcCtD
Propranolol—Disorientation—Topiramate—obesity	0.000112	0.00225	CcSEcCtD
Propranolol—CYP3A5—digestive system—obesity	0.000111	0.00873	CbGeAlD
Propranolol—Vomiting—Diethylpropion—obesity	0.00011	0.00222	CcSEcCtD
Propranolol—Alopecia—Sibutramine—obesity	0.00011	0.00221	CcSEcCtD
Propranolol—Rash—Diethylpropion—obesity	0.00011	0.00221	CcSEcCtD
Propranolol—Dermatitis—Diethylpropion—obesity	0.000109	0.0022	CcSEcCtD
Propranolol—Dizziness—Cimetidine—obesity	0.000109	0.0022	CcSEcCtD
Propranolol—Hallucination—Bupropion—obesity	0.000108	0.00217	CcSEcCtD
Propranolol—Pharyngitis—Bupropion—obesity	0.000108	0.00217	CcSEcCtD
Propranolol—Amnesia—Topiramate—obesity	0.000106	0.00214	CcSEcCtD
Propranolol—Bopindolol—ADRB3—obesity	0.000105	0.0408	CrCbGaD
Propranolol—Visual disturbance—Topiramate—obesity	0.000105	0.00212	CcSEcCtD
Propranolol—Vomiting—Cimetidine—obesity	0.000105	0.00212	CcSEcCtD
Propranolol—CYP2C19—liver—obesity	0.000105	0.00826	CbGeAlD
Propranolol—Visual impairment—Bupropion—obesity	0.000104	0.0021	CcSEcCtD
Propranolol—Rash—Cimetidine—obesity	0.000104	0.0021	CcSEcCtD
Propranolol—Dermatitis—Cimetidine—obesity	0.000104	0.0021	CcSEcCtD
Propranolol—Purpura—Topiramate—obesity	0.000104	0.00208	CcSEcCtD
Propranolol—Nausea—Diethylpropion—obesity	0.000103	0.00208	CcSEcCtD
Propranolol—Erythema multiforme—Bupropion—obesity	0.000102	0.00206	CcSEcCtD
Propranolol—Hypoglycaemia—Topiramate—obesity	0.000102	0.00206	CcSEcCtD
Propranolol—Lethargy—Topiramate—obesity	0.000102	0.00205	CcSEcCtD
Propranolol—Cardiac disorder—Bupropion—obesity	0.000101	0.00203	CcSEcCtD
Propranolol—Vertigo—Orlistat—obesity	0.0001	0.00202	CcSEcCtD
Propranolol—Agitation—Sibutramine—obesity	9.95e-05	0.002	CcSEcCtD
Propranolol—Affect lability—Topiramate—obesity	9.83e-05	0.00198	CcSEcCtD
Propranolol—Nausea—Cimetidine—obesity	9.82e-05	0.00198	CcSEcCtD
Propranolol—ABCB1—islet of Langerhans—obesity	9.81e-05	0.00772	CbGeAlD
Propranolol—Atomoxetine—NPY1R—obesity	9.8e-05	0.038	CrCbGaD
Propranolol—Cough—Orlistat—obesity	9.76e-05	0.00196	CcSEcCtD
Propranolol—Vertigo—Sibutramine—obesity	9.72e-05	0.00196	CcSEcCtD
Propranolol—Convulsion—Orlistat—obesity	9.69e-05	0.00195	CcSEcCtD
Propranolol—Alopecia—Bupropion—obesity	9.58e-05	0.00193	CcSEcCtD
Propranolol—Irritability—Topiramate—obesity	9.53e-05	0.00192	CcSEcCtD
Propranolol—CYP1A2—endocrine gland—obesity	9.5e-05	0.00748	CbGeAlD
Propranolol—Mental disorder—Bupropion—obesity	9.5e-05	0.00191	CcSEcCtD
Propranolol—Mood swings—Topiramate—obesity	9.46e-05	0.0019	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	9.46e-05	0.0019	CcSEcCtD
Propranolol—Cough—Sibutramine—obesity	9.44e-05	0.0019	CcSEcCtD
Propranolol—Convulsion—Sibutramine—obesity	9.38e-05	0.00189	CcSEcCtD
Propranolol—CYP1A1—endocrine gland—obesity	9.37e-05	0.00738	CbGeAlD
Propranolol—ABCB1—respiratory system—obesity	9.27e-05	0.00729	CbGeAlD
Propranolol—CYP3A5—endocrine gland—obesity	9.16e-05	0.00721	CbGeAlD
Propranolol—Anaphylactic shock—Orlistat—obesity	9.13e-05	0.00184	CcSEcCtD
Propranolol—Infection—Orlistat—obesity	9.07e-05	0.00183	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Topiramate—obesity	8.99e-05	0.00181	CcSEcCtD
Propranolol—Nervous system disorder—Orlistat—obesity	8.95e-05	0.0018	CcSEcCtD
Propranolol—Skin disorder—Orlistat—obesity	8.87e-05	0.00178	CcSEcCtD
Propranolol—Anaphylactic shock—Sibutramine—obesity	8.83e-05	0.00178	CcSEcCtD
Propranolol—Infection—Sibutramine—obesity	8.78e-05	0.00177	CcSEcCtD
Propranolol—Agitation—Bupropion—obesity	8.67e-05	0.00175	CcSEcCtD
Propranolol—Skin disorder—Sibutramine—obesity	8.58e-05	0.00173	CcSEcCtD
Propranolol—CYP1A2—liver—obesity	8.57e-05	0.00674	CbGeAlD
Propranolol—Vertigo—Bupropion—obesity	8.48e-05	0.00171	CcSEcCtD
Propranolol—CYP1A1—liver—obesity	8.45e-05	0.00665	CbGeAlD
Propranolol—Alprenolol—ADRB3—obesity	8.43e-05	0.0327	CrCbGaD
Propranolol—CYP3A4—digestive system—obesity	8.32e-05	0.00655	CbGeAlD
Propranolol—Bronchitis—Topiramate—obesity	8.3e-05	0.00167	CcSEcCtD
Propranolol—CYP3A5—liver—obesity	8.26e-05	0.0065	CbGeAlD
Propranolol—Insomnia—Orlistat—obesity	8.26e-05	0.00166	CcSEcCtD
Propranolol—Cough—Bupropion—obesity	8.23e-05	0.00166	CcSEcCtD
Propranolol—Paraesthesia—Orlistat—obesity	8.2e-05	0.00165	CcSEcCtD
Propranolol—CYP2D6—digestive system—obesity	8.19e-05	0.00645	CbGeAlD
Propranolol—Convulsion—Bupropion—obesity	8.18e-05	0.00165	CcSEcCtD
Propranolol—Neutropenia—Topiramate—obesity	8.07e-05	0.00162	CcSEcCtD
Propranolol—Dyspepsia—Orlistat—obesity	8.03e-05	0.00162	CcSEcCtD
Propranolol—Insomnia—Sibutramine—obesity	7.99e-05	0.00161	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	7.98e-05	0.00161	CcSEcCtD
Propranolol—Erectile dysfunction—Topiramate—obesity	7.95e-05	0.0016	CcSEcCtD
Propranolol—Decreased appetite—Orlistat—obesity	7.93e-05	0.0016	CcSEcCtD
Propranolol—Paraesthesia—Sibutramine—obesity	7.93e-05	0.0016	CcSEcCtD
Propranolol—Gastrointestinal disorder—Orlistat—obesity	7.88e-05	0.00159	CcSEcCtD
Propranolol—Dyspnoea—Sibutramine—obesity	7.88e-05	0.00159	CcSEcCtD
Propranolol—Fatigue—Orlistat—obesity	7.87e-05	0.00158	CcSEcCtD
Propranolol—Somnolence—Sibutramine—obesity	7.85e-05	0.00158	CcSEcCtD
Propranolol—Pain—Orlistat—obesity	7.81e-05	0.00157	CcSEcCtD
Propranolol—ABCB1—adrenal cortex—obesity	7.78e-05	0.00612	CbGeAlD
Propranolol—Dyspepsia—Sibutramine—obesity	7.78e-05	0.00157	CcSEcCtD
Propranolol—Anaphylactic shock—Bupropion—obesity	7.7e-05	0.00155	CcSEcCtD
Propranolol—Infestation NOS—Topiramate—obesity	7.69e-05	0.00155	CcSEcCtD
Propranolol—Infestation—Topiramate—obesity	7.69e-05	0.00155	CcSEcCtD
Propranolol—Decreased appetite—Sibutramine—obesity	7.68e-05	0.00155	CcSEcCtD
Propranolol—Depression—Topiramate—obesity	7.67e-05	0.00154	CcSEcCtD
Propranolol—Infection—Bupropion—obesity	7.65e-05	0.00154	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Topiramate—obesity	7.63e-05	0.00154	CcSEcCtD
Propranolol—Gastrointestinal disorder—Sibutramine—obesity	7.63e-05	0.00154	CcSEcCtD
Propranolol—Pain—Sibutramine—obesity	7.55e-05	0.00152	CcSEcCtD
Propranolol—Constipation—Sibutramine—obesity	7.55e-05	0.00152	CcSEcCtD
Propranolol—Nervous system disorder—Bupropion—obesity	7.55e-05	0.00152	CcSEcCtD
Propranolol—Skin disorder—Bupropion—obesity	7.48e-05	0.00151	CcSEcCtD
Propranolol—Gastrointestinal pain—Orlistat—obesity	7.46e-05	0.0015	CcSEcCtD
Propranolol—Practolol—ADRB1—obesity	7.26e-05	0.0281	CrCbGaD
Propranolol—Pindolol—ADRB3—obesity	7.25e-05	0.0281	CrCbGaD
Propranolol—Urticaria—Orlistat—obesity	7.25e-05	0.00146	CcSEcCtD
Propranolol—Gastrointestinal pain—Sibutramine—obesity	7.22e-05	0.00145	CcSEcCtD
Propranolol—Abdominal pain—Orlistat—obesity	7.22e-05	0.00145	CcSEcCtD
Propranolol—Body temperature increased—Orlistat—obesity	7.22e-05	0.00145	CcSEcCtD
Propranolol—Agranulocytosis—Topiramate—obesity	7.18e-05	0.00145	CcSEcCtD
Propranolol—ABCB1—cardiovascular system—obesity	7.1e-05	0.00559	CbGeAlD
Propranolol—Bradycardia—Topiramate—obesity	7.03e-05	0.00142	CcSEcCtD
Propranolol—Urticaria—Sibutramine—obesity	7.02e-05	0.00141	CcSEcCtD
Propranolol—Body temperature increased—Sibutramine—obesity	6.98e-05	0.00141	CcSEcCtD
Propranolol—Abdominal pain—Sibutramine—obesity	6.98e-05	0.00141	CcSEcCtD
Propranolol—Insomnia—Bupropion—obesity	6.97e-05	0.0014	CcSEcCtD
Propranolol—Paraesthesia—Bupropion—obesity	6.91e-05	0.00139	CcSEcCtD
Propranolol—Levobunolol—ADRB1—obesity	6.88e-05	0.0266	CrCbGaD
Propranolol—CYP3A4—endocrine gland—obesity	6.88e-05	0.00541	CbGeAlD
Propranolol—Hallucination—Topiramate—obesity	6.87e-05	0.00138	CcSEcCtD
Propranolol—Dyspnoea—Bupropion—obesity	6.87e-05	0.00138	CcSEcCtD
Propranolol—Pharyngitis—Topiramate—obesity	6.85e-05	0.00138	CcSEcCtD
Propranolol—Somnolence—Bupropion—obesity	6.85e-05	0.00138	CcSEcCtD
Propranolol—Dyspepsia—Bupropion—obesity	6.78e-05	0.00136	CcSEcCtD
Propranolol—CYP2D6—endocrine gland—obesity	6.77e-05	0.00533	CbGeAlD
Propranolol—Hypersensitivity—Orlistat—obesity	6.72e-05	0.00135	CcSEcCtD
Propranolol—Decreased appetite—Bupropion—obesity	6.69e-05	0.00135	CcSEcCtD
Propranolol—Visual impairment—Topiramate—obesity	6.65e-05	0.00134	CcSEcCtD
Propranolol—Gastrointestinal disorder—Bupropion—obesity	6.65e-05	0.00134	CcSEcCtD
Propranolol—Fatigue—Bupropion—obesity	6.64e-05	0.00134	CcSEcCtD
Propranolol—Pain—Bupropion—obesity	6.59e-05	0.00133	CcSEcCtD
Propranolol—Constipation—Bupropion—obesity	6.59e-05	0.00133	CcSEcCtD
Propranolol—Metipranolol—ADRB1—obesity	6.56e-05	0.0254	CrCbGaD
Propranolol—Asthenia—Orlistat—obesity	6.55e-05	0.00132	CcSEcCtD
Propranolol—Erythema multiforme—Topiramate—obesity	6.53e-05	0.00131	CcSEcCtD
Propranolol—Hypersensitivity—Sibutramine—obesity	6.51e-05	0.00131	CcSEcCtD
Propranolol—Cardiac disorder—Topiramate—obesity	6.41e-05	0.00129	CcSEcCtD
Propranolol—Asthenia—Sibutramine—obesity	6.34e-05	0.00128	CcSEcCtD
Propranolol—Gastrointestinal pain—Bupropion—obesity	6.3e-05	0.00127	CcSEcCtD
Propranolol—ABCB1—pituitary gland—obesity	6.28e-05	0.00495	CbGeAlD
Propranolol—ABCB1—adipose tissue—obesity	6.26e-05	0.00493	CbGeAlD
Propranolol—Diarrhoea—Orlistat—obesity	6.25e-05	0.00126	CcSEcCtD
Propranolol—CYP3A4—liver—obesity	6.2e-05	0.00488	CbGeAlD
Propranolol—Urticaria—Bupropion—obesity	6.12e-05	0.00123	CcSEcCtD
Propranolol—Alopecia—Topiramate—obesity	6.1e-05	0.00123	CcSEcCtD
Propranolol—CYP2D6—liver—obesity	6.1e-05	0.0048	CbGeAlD
Propranolol—Body temperature increased—Bupropion—obesity	6.09e-05	0.00123	CcSEcCtD
Propranolol—Abdominal pain—Bupropion—obesity	6.09e-05	0.00123	CcSEcCtD
Propranolol—Mental disorder—Topiramate—obesity	6.05e-05	0.00122	CcSEcCtD
Propranolol—Diarrhoea—Sibutramine—obesity	6.04e-05	0.00122	CcSEcCtD
Propranolol—Dizziness—Orlistat—obesity	6.04e-05	0.00122	CcSEcCtD
Propranolol—Erythema—Topiramate—obesity	6.01e-05	0.00121	CcSEcCtD
Propranolol—ABCB1—digestive system—obesity	5.89e-05	0.00464	CbGeAlD
Propranolol—Carteolol—ADRB1—obesity	5.85e-05	0.0227	CrCbGaD
Propranolol—Dizziness—Sibutramine—obesity	5.84e-05	0.00118	CcSEcCtD
Propranolol—Vomiting—Orlistat—obesity	5.8e-05	0.00117	CcSEcCtD
Propranolol—Levobunolol—ADRB2—obesity	5.78e-05	0.0224	CrCbGaD
Propranolol—Rash—Orlistat—obesity	5.75e-05	0.00116	CcSEcCtD
Propranolol—Dermatitis—Orlistat—obesity	5.75e-05	0.00116	CcSEcCtD
Propranolol—Hypersensitivity—Bupropion—obesity	5.67e-05	0.00114	CcSEcCtD
Propranolol—Vomiting—Sibutramine—obesity	5.62e-05	0.00113	CcSEcCtD
Propranolol—ABCB1—adrenal gland—obesity	5.61e-05	0.00442	CbGeAlD
Propranolol—Rash—Sibutramine—obesity	5.57e-05	0.00112	CcSEcCtD
Propranolol—Dermatitis—Sibutramine—obesity	5.56e-05	0.00112	CcSEcCtD
Propranolol—Acebutolol—SLC22A1—obesity	5.53e-05	0.0214	CrCbGaD
Propranolol—Asthenia—Bupropion—obesity	5.53e-05	0.00111	CcSEcCtD
Propranolol—Agitation—Topiramate—obesity	5.52e-05	0.00111	CcSEcCtD
Propranolol—Metipranolol—ADRB2—obesity	5.52e-05	0.0214	CrCbGaD
Propranolol—Nausea—Orlistat—obesity	5.42e-05	0.00109	CcSEcCtD
Propranolol—Vertigo—Topiramate—obesity	5.4e-05	0.00109	CcSEcCtD
Propranolol—Bopindolol—HTR1B—obesity	5.39e-05	0.0209	CrCbGaD
Propranolol—Diarrhoea—Bupropion—obesity	5.27e-05	0.00106	CcSEcCtD
Propranolol—Nausea—Sibutramine—obesity	5.25e-05	0.00106	CcSEcCtD
Propranolol—Cough—Topiramate—obesity	5.25e-05	0.00106	CcSEcCtD
Propranolol—Esmolol—ADRB1—obesity	5.21e-05	0.0202	CrCbGaD
Propranolol—Convulsion—Topiramate—obesity	5.21e-05	0.00105	CcSEcCtD
Propranolol—Carvedilol—ADRB3—obesity	5.2e-05	0.0202	CrCbGaD
Propranolol—Bevantolol—ADRB1—obesity	5.15e-05	0.0199	CrCbGaD
Propranolol—Penbutolol—HTR1B—obesity	5.14e-05	0.0199	CrCbGaD
Propranolol—Dizziness—Bupropion—obesity	5.09e-05	0.00103	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	5.08e-05	0.00102	CcSEcCtD
Propranolol—Carteolol—ADRB2—obesity	4.92e-05	0.0191	CrCbGaD
Propranolol—Vomiting—Bupropion—obesity	4.9e-05	0.000986	CcSEcCtD
Propranolol—Infection—Topiramate—obesity	4.87e-05	0.000981	CcSEcCtD
Propranolol—ABCB1—endocrine gland—obesity	4.87e-05	0.00383	CbGeAlD
Propranolol—Rash—Bupropion—obesity	4.86e-05	0.000977	CcSEcCtD
Propranolol—Dermatitis—Bupropion—obesity	4.85e-05	0.000977	CcSEcCtD
Propranolol—Nervous system disorder—Topiramate—obesity	4.81e-05	0.000969	CcSEcCtD
Propranolol—Bopindolol—ADRB1—obesity	4.77e-05	0.0185	CrCbGaD
Propranolol—Skin disorder—Topiramate—obesity	4.77e-05	0.000959	CcSEcCtD
Propranolol—Terbinafine—CYP19A1—obesity	4.67e-05	0.0181	CrCbGaD
Propranolol—Betaxolol—ADRB1—obesity	4.59e-05	0.0178	CrCbGaD
Propranolol—Nausea—Bupropion—obesity	4.57e-05	0.000921	CcSEcCtD
Propranolol—Atenolol—ADRB1—obesity	4.55e-05	0.0176	CrCbGaD
Propranolol—Penbutolol—ADRB1—obesity	4.55e-05	0.0176	CrCbGaD
Propranolol—Insomnia—Topiramate—obesity	4.44e-05	0.000893	CcSEcCtD
Propranolol—Bisoprolol—ADRB1—obesity	4.43e-05	0.0172	CrCbGaD
Propranolol—Paraesthesia—Topiramate—obesity	4.41e-05	0.000887	CcSEcCtD
Propranolol—ABCB1—liver—obesity	4.39e-05	0.00345	CbGeAlD
Propranolol—Esmolol—ADRB2—obesity	4.38e-05	0.017	CrCbGaD
Propranolol—Dyspnoea—Topiramate—obesity	4.37e-05	0.000881	CcSEcCtD
Propranolol—Somnolence—Topiramate—obesity	4.36e-05	0.000878	CcSEcCtD
Propranolol—Bevantolol—ADRB2—obesity	4.33e-05	0.0168	CrCbGaD
Propranolol—Dyspepsia—Topiramate—obesity	4.32e-05	0.000869	CcSEcCtD
Propranolol—Decreased appetite—Topiramate—obesity	4.26e-05	0.000859	CcSEcCtD
Propranolol—Gastrointestinal disorder—Topiramate—obesity	4.24e-05	0.000853	CcSEcCtD
Propranolol—Fatigue—Topiramate—obesity	4.23e-05	0.000851	CcSEcCtD
Propranolol—Acebutolol—ADRB1—obesity	4.2e-05	0.0163	CrCbGaD
Propranolol—Pain—Topiramate—obesity	4.2e-05	0.000845	CcSEcCtD
Propranolol—Constipation—Topiramate—obesity	4.2e-05	0.000845	CcSEcCtD
Propranolol—Oxprenolol—ADRB1—obesity	4.17e-05	0.0161	CrCbGaD
Propranolol—Gastrointestinal pain—Topiramate—obesity	4.01e-05	0.000808	CcSEcCtD
Propranolol—Bopindolol—ADRB2—obesity	4.01e-05	0.0155	CrCbGaD
Propranolol—Urticaria—Topiramate—obesity	3.9e-05	0.000785	CcSEcCtD
Propranolol—Abdominal pain—Topiramate—obesity	3.88e-05	0.000781	CcSEcCtD
Propranolol—Body temperature increased—Topiramate—obesity	3.88e-05	0.000781	CcSEcCtD
Propranolol—Betaxolol—ADRB2—obesity	3.86e-05	0.015	CrCbGaD
Propranolol—Atenolol—ADRB2—obesity	3.82e-05	0.0148	CrCbGaD
Propranolol—Penbutolol—ADRB2—obesity	3.82e-05	0.0148	CrCbGaD
Propranolol—Alprenolol—ADRB1—obesity	3.81e-05	0.0148	CrCbGaD
Propranolol—Bisoprolol—ADRB2—obesity	3.73e-05	0.0144	CrCbGaD
Propranolol—Pindolol—HTR1B—obesity	3.71e-05	0.0144	CrCbGaD
Propranolol—Hypersensitivity—Topiramate—obesity	3.61e-05	0.000728	CcSEcCtD
Propranolol—Metoprolol—ADRB1—obesity	3.54e-05	0.0137	CrCbGaD
Propranolol—Acebutolol—ADRB2—obesity	3.53e-05	0.0137	CrCbGaD
Propranolol—Asthenia—Topiramate—obesity	3.52e-05	0.000709	CcSEcCtD
Propranolol—Oxprenolol—ADRB2—obesity	3.5e-05	0.0136	CrCbGaD
Propranolol—Diarrhoea—Topiramate—obesity	3.36e-05	0.000676	CcSEcCtD
Propranolol—Duloxetine—HTR2C—obesity	3.31e-05	0.0128	CrCbGaD
Propranolol—Pindolol—ADRB1—obesity	3.28e-05	0.0127	CrCbGaD
Propranolol—Dizziness—Topiramate—obesity	3.24e-05	0.000653	CcSEcCtD
Propranolol—Alprenolol—ADRB2—obesity	3.21e-05	0.0124	CrCbGaD
Propranolol—Vomiting—Topiramate—obesity	3.12e-05	0.000628	CcSEcCtD
Propranolol—Rash—Topiramate—obesity	3.09e-05	0.000623	CcSEcCtD
Propranolol—Dermatitis—Topiramate—obesity	3.09e-05	0.000622	CcSEcCtD
Propranolol—Metoprolol—ADRB2—obesity	2.98e-05	0.0115	CrCbGaD
Propranolol—Nausea—Topiramate—obesity	2.91e-05	0.000587	CcSEcCtD
Propranolol—Pindolol—ADRB2—obesity	2.76e-05	0.0107	CrCbGaD
Propranolol—Duloxetine—SLC6A4—obesity	2.75e-05	0.0106	CrCbGaD
Propranolol—Propafenone—ADRB1—obesity	2.61e-05	0.0101	CrCbGaD
Propranolol—Carvedilol—ADRB1—obesity	2.35e-05	0.00911	CrCbGaD
Propranolol—Atomoxetine—HTR1B—obesity	2.13e-05	0.00825	CrCbGaD
Propranolol—Duloxetine—HTR2A—obesity	2.11e-05	0.00817	CrCbGaD
Propranolol—Carvedilol—ADRB2—obesity	1.98e-05	0.00766	CrCbGaD
Propranolol—Atomoxetine—HTR2C—obesity	1.74e-05	0.00672	CrCbGaD
Propranolol—Carvedilol—CYP2E1—obesity	1.72e-05	0.00666	CrCbGaD
Propranolol—Atomoxetine—SLC6A4—obesity	1.44e-05	0.00557	CrCbGaD
Propranolol—Atomoxetine—HTR2A—obesity	1.11e-05	0.00428	CrCbGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	9.91e-07	2.14e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TYK2—obesity	9.9e-07	2.14e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—LPL—obesity	9.86e-07	2.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CD—obesity	9.85e-07	2.12e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RHOA—obesity	9.82e-07	2.12e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—obesity	9.79e-07	2.11e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC2A4—obesity	9.79e-07	2.11e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GCG—obesity	9.79e-07	2.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NAMPT—obesity	9.78e-07	2.11e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—obesity	9.75e-07	2.1e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SERPINE1—obesity	9.74e-07	2.1e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOS3—obesity	9.72e-07	2.1e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3R1—obesity	9.72e-07	2.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LIPC—obesity	9.71e-07	2.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCK—obesity	9.71e-07	2.1e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GNAS—obesity	9.7e-07	2.09e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TYK2—obesity	9.69e-07	2.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYCS—obesity	9.66e-07	2.08e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOC3—obesity	9.65e-07	2.08e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CG—obesity	9.65e-07	2.08e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—LPL—obesity	9.62e-07	2.08e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—obesity	9.62e-07	2.07e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RHOA—obesity	9.61e-07	2.07e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.56e-07	2.06e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK8—obesity	9.52e-07	2.05e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3R1—obesity	9.51e-07	2.05e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOS3—obesity	9.51e-07	2.05e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—obesity	9.5e-07	2.05e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOB—obesity	9.5e-07	2.05e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GGT1—obesity	9.48e-07	2.04e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GOT1—obesity	9.48e-07	2.04e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TYK2—obesity	9.47e-07	2.04e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RHOA—obesity	9.39e-07	2.03e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—obesity	9.39e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CETP—obesity	9.37e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CD36—obesity	9.37e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NCOA1—obesity	9.34e-07	2.01e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—obesity	9.31e-07	2.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—obesity	9.3e-07	2.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3R1—obesity	9.3e-07	2.01e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SDC1—obesity	9.27e-07	2e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	9.26e-07	2e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—obesity	9.21e-07	1.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—STK11—obesity	9.2e-07	1.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP19A1—obesity	9.2e-07	1.99e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—obesity	9.18e-07	1.98e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CD36—obesity	9.14e-07	1.97e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—INS—obesity	9.13e-07	1.97e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKR1C3—obesity	9.12e-07	1.97e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—obesity	9.11e-07	1.97e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—LPL—obesity	9.07e-07	1.96e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	9.06e-07	1.95e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SCARB1—obesity	8.98e-07	1.94e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CB—obesity	8.97e-07	1.94e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MTOR—obesity	8.97e-07	1.94e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—obesity	8.88e-07	1.91e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—obesity	8.86e-07	1.91e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—obesity	8.85e-07	1.91e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—obesity	8.8e-07	1.9e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MTOR—obesity	8.78e-07	1.89e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CB—obesity	8.78e-07	1.89e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SREBF1—obesity	8.71e-07	1.88e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARA—obesity	8.71e-07	1.88e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—obesity	8.71e-07	1.88e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—obesity	8.68e-07	1.87e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—obesity	8.66e-07	1.87e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—INS—obesity	8.63e-07	1.86e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CD36—obesity	8.62e-07	1.86e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MTOR—obesity	8.58e-07	1.85e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CB—obesity	8.58e-07	1.85e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—COMT—obesity	8.56e-07	1.85e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARA—obesity	8.5e-07	1.83e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CD—obesity	8.48e-07	1.83e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GOT2—obesity	8.48e-07	1.83e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARGC1A—obesity	8.44e-07	1.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNB3—obesity	8.44e-07	1.82e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AGT—obesity	8.43e-07	1.82e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—obesity	8.4e-07	1.81e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—obesity	8.37e-07	1.81e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—obesity	8.33e-07	1.8e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—FASN—obesity	8.3e-07	1.79e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—obesity	8.26e-07	1.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—obesity	8.26e-07	1.78e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AGT—obesity	8.23e-07	1.78e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNAS—obesity	8.22e-07	1.77e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—obesity	8.2e-07	1.77e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAV1—obesity	8.19e-07	1.77e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOA1—obesity	8.17e-07	1.76e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—obesity	8.16e-07	1.76e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—obesity	8.16e-07	1.76e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—obesity	8.15e-07	1.76e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—obesity	8.09e-07	1.74e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—obesity	8.07e-07	1.74e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—obesity	8.07e-07	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOB—obesity	8.04e-07	1.74e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—obesity	8.02e-07	1.73e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CD—obesity	8.01e-07	1.73e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARA—obesity	8.01e-07	1.73e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—obesity	8.01e-07	1.73e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3R1—obesity	8.01e-07	1.73e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAV1—obesity	7.99e-07	1.72e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOA1—obesity	7.97e-07	1.72e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2E1—obesity	7.97e-07	1.72e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—obesity	7.97e-07	1.72e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—obesity	7.91e-07	1.71e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NQO1—obesity	7.88e-07	1.7e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—obesity	7.84e-07	1.69e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.82e-07	1.69e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—obesity	7.8e-07	1.68e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AGT—obesity	7.76e-07	1.67e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—LPL—obesity	7.68e-07	1.66e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—obesity	7.63e-07	1.65e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—obesity	7.6e-07	1.64e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK8—obesity	7.58e-07	1.64e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—obesity	7.57e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3R1—obesity	7.57e-07	1.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—obesity	7.56e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCG—obesity	7.56e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A4—obesity	7.56e-07	1.63e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAV1—obesity	7.53e-07	1.62e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—obesity	7.53e-07	1.62e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOA1—obesity	7.51e-07	1.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—obesity	7.49e-07	1.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—obesity	7.46e-07	1.61e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—obesity	7.46e-07	1.61e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYCS—obesity	7.46e-07	1.61e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK8—obesity	7.42e-07	1.6e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—obesity	7.4e-07	1.6e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CB—obesity	7.39e-07	1.59e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—obesity	7.32e-07	1.58e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GOT1—obesity	7.32e-07	1.58e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GGT1—obesity	7.32e-07	1.58e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CD36—obesity	7.3e-07	1.57e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—obesity	7.28e-07	1.57e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK8—obesity	7.25e-07	1.56e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—obesity	7.23e-07	1.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOA1—obesity	7.21e-07	1.55e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—obesity	7.2e-07	1.55e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—STK11—obesity	7.1e-07	1.53e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP19A1—obesity	7.1e-07	1.53e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—obesity	7.1e-07	1.53e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—INS—obesity	7.06e-07	1.52e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—obesity	7.03e-07	1.52e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CB—obesity	6.98e-07	1.51e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—obesity	6.93e-07	1.5e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—obesity	6.93e-07	1.49e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—obesity	6.92e-07	1.49e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—obesity	6.92e-07	1.49e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—INS—obesity	6.89e-07	1.49e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—obesity	6.87e-07	1.48e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—obesity	6.86e-07	1.48e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARA—obesity	6.79e-07	1.46e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—obesity	6.78e-07	1.46e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—obesity	6.63e-07	1.43e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—obesity	6.62e-07	1.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—COMT—obesity	6.6e-07	1.42e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AGT—obesity	6.57e-07	1.42e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CD—obesity	6.56e-07	1.41e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—obesity	6.53e-07	1.41e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARGC1A—obesity	6.51e-07	1.4e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNB3—obesity	6.51e-07	1.4e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—INS—obesity	6.49e-07	1.4e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—obesity	6.48e-07	1.4e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—obesity	6.47e-07	1.4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—obesity	6.44e-07	1.39e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—obesity	6.44e-07	1.39e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—obesity	6.43e-07	1.39e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CD—obesity	6.4e-07	1.38e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAV1—obesity	6.38e-07	1.38e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOA1—obesity	6.37e-07	1.37e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNAS—obesity	6.34e-07	1.37e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—obesity	6.32e-07	1.36e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—obesity	6.3e-07	1.36e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—obesity	6.29e-07	1.36e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—obesity	6.23e-07	1.34e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—obesity	6.22e-07	1.34e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOB—obesity	6.21e-07	1.34e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3R1—obesity	6.19e-07	1.34e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—obesity	6.19e-07	1.34e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—obesity	6.16e-07	1.33e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—obesity	6.15e-07	1.33e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.1e-07	1.31e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—obesity	6.08e-07	1.31e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—obesity	6.04e-07	1.3e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3R1—obesity	6.04e-07	1.3e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CD—obesity	6.03e-07	1.3e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—obesity	5.95e-07	1.28e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LPL—obesity	5.93e-07	1.28e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—obesity	5.81e-07	1.25e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—obesity	5.78e-07	1.25e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CB—obesity	5.71e-07	1.23e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3R1—obesity	5.69e-07	1.23e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—obesity	5.69e-07	1.23e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—obesity	5.66e-07	1.22e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CD36—obesity	5.63e-07	1.21e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—obesity	5.61e-07	1.21e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—obesity	5.61e-07	1.21e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CB—obesity	5.58e-07	1.2e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—obesity	5.53e-07	1.19e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—obesity	5.53e-07	1.19e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—INS—obesity	5.5e-07	1.19e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—obesity	5.47e-07	1.18e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—obesity	5.35e-07	1.15e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—obesity	5.34e-07	1.15e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CB—obesity	5.26e-07	1.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARA—obesity	5.24e-07	1.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—obesity	5.23e-07	1.13e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—obesity	5.21e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CD—obesity	5.11e-07	1.1e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—obesity	5.09e-07	1.1e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—obesity	5.08e-07	1.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AGT—obesity	5.07e-07	1.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—obesity	5.04e-07	1.09e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—obesity	4.97e-07	1.07e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAV1—obesity	4.92e-07	1.06e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOA1—obesity	4.91e-07	1.06e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—obesity	4.84e-07	1.04e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—obesity	4.82e-07	1.04e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3R1—obesity	4.82e-07	1.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—obesity	4.74e-07	1.02e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—obesity	4.63e-07	9.99e-06	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—obesity	4.51e-07	9.72e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—obesity	4.48e-07	9.67e-06	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—obesity	4.47e-07	9.64e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CB—obesity	4.45e-07	9.6e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—obesity	4.41e-07	9.52e-06	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—obesity	4.37e-07	9.43e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—obesity	4.33e-07	9.34e-06	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—obesity	4.27e-07	9.22e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—obesity	4.27e-07	9.21e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—obesity	4.26e-07	9.18e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—INS—obesity	4.25e-07	9.16e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CD—obesity	3.94e-07	8.5e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—obesity	3.89e-07	8.39e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3R1—obesity	3.72e-07	8.03e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—obesity	3.72e-07	8.03e-06	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—obesity	3.68e-07	7.94e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—obesity	3.48e-07	7.51e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—obesity	3.48e-07	7.5e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CB—obesity	3.44e-07	7.41e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—obesity	3.41e-07	7.34e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—obesity	3.4e-07	7.33e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—obesity	3.2e-07	6.91e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—obesity	2.85e-07	6.14e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—obesity	2.78e-07	5.99e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—obesity	2.71e-07	5.85e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—obesity	2.62e-07	5.65e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—obesity	2.22e-07	4.78e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—obesity	2.09e-07	4.52e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—obesity	1.71e-07	3.69e-06	CbGpPWpGaD
